AtriCure Files Proxy Materials for Annual Meeting
Ticker: ATRC · Form: DEFA14A · Filed: Apr 3, 2024 · CIK: 1323885
Sentiment: neutral
Topics: proxy, annual-meeting, governance
Related Tickers: ATRC
TL;DR
AtriCure's proxy filing is out - vote on directors & auditors for 2024.
AI Summary
AtriCure, Inc. filed a Definitive Additional Materials proxy statement on April 3, 2024. This filing relates to the company's annual meeting of stockholders, where key proposals such as the election of directors and the ratification of PricewaterhouseCoopers LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2024, will be voted upon.
Why It Matters
This filing provides shareholders with essential information and voting materials for the company's annual meeting, allowing them to participate in corporate governance decisions.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting and does not contain new financial risks or significant strategic changes.
Key Players & Entities
- AtriCure, Inc. (company) — Registrant
- PricewaterhouseCoopers LLP (company) — Independent registered public accounting firm
FAQ
What is the purpose of this DEFA14A filing?
This filing is a Definitive Additional Materials proxy statement for AtriCure, Inc., providing shareholders with information for their annual meeting.
When was this filing made?
The filing was made on April 3, 2024.
What are the main items to be voted on at the meeting?
The filing indicates proposals for the election of directors and the ratification of the independent registered public accounting firm.
Who is AtriCure, Inc.'s independent registered public accounting firm for the upcoming fiscal year?
PricewaterhouseCoopers LLP is proposed to be ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
What is AtriCure, Inc.'s fiscal year end?
AtriCure, Inc.'s fiscal year ends on December 31.
Filing Stats: 129 words · 1 min read · ~1 pages · Grade level 15.8 · Accepted 2024-04-03 17:09:33
Filing Documents
- a2024atricureproxynotice-d.htm (DEFA14A) — 10KB
- proxycardback-c2.jpg (GRAPHIC) — 194KB
- proxycardfront-c2.jpg (GRAPHIC) — 281KB
- proxynoticeback-c2.jpg (GRAPHIC) — 261KB
- proxynoticefront-c2.jpg (GRAPHIC) — 192KB
- 0001323885-24-000057.txt ( ) — 1289KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 14a-11(c) or Rule 14a-12 AtriCure, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply) No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.